Breaking News
February 22, 2019 - Researchers create new map of the brain’s own immune system
February 22, 2019 - ICHE’s reviews on surgical infections, unnecessary urine tests, and nurses’ role in antibiotic stewardship
February 22, 2019 - UK Research and Innovation invests £200 million to create new generation of AI leaders
February 22, 2019 - Takeda collaboration to boost fight against Alzheimer’s and other neurodegenerative diseases
February 22, 2019 - Heavy drinking may change DNA, leading to increased craving for alcohol
February 22, 2019 - U.S. opioid deaths jump fourfold in 20 years; epidemic shifts to Eastern states | News Center
February 22, 2019 - 5 Questions with William Turner on Diversity in Medicine
February 22, 2019 - HHS Finalizes Rule Seeking To Expel Planned Parenthood From Family Planning Program
February 22, 2019 - Researchers uncover biochemical pathway that may help identify drugs to treat Alzheimer’s
February 22, 2019 - Biologist uses new grant to find ways to eliminate schistosomiasis
February 22, 2019 - Bag-mask ventilation to help patients breathe during intubation prevents complications
February 22, 2019 - AbbVie Announces New Drug Application Accepted for Priority Review by FDA for Upadacitinib for Treatment of Moderate to Severe Rheumatoid Arthritis
February 22, 2019 - Nature versus nurture and addiction
February 22, 2019 - New website connects researchers with data experts, resources | News Center
February 22, 2019 - Today’s Concerns About Drug Prices Echo The Past
February 22, 2019 - CT and Doppler equipment have low accuracy in detecting cerebral vasospasm and ischemia
February 22, 2019 - Study finds out similarity in function between healthy retina cell and tumor cell
February 22, 2019 - CWRU awarded NIH grant to identify effective treatments for intimate partner violence
February 22, 2019 - Oncotype DX Not Cost-Effective for Low-Risk Breast Cancer
February 22, 2019 - Scientists discover new type of immune cells that are essential for forming heart valves
February 22, 2019 - Talk About Déjà Vu: Senators Set To Re-Enact Drug Price Hearing Of 60 Years Ago
February 22, 2019 - Genetic defect linked to pediatric liver disease identified
February 22, 2019 - New cellular atlas could provide a deeper insight into blinding diseases
February 22, 2019 - Growing number of cancer survivors, fewer providers point to challenge in meeting care needs
February 22, 2019 - Innovative compound offers a new therapeutic approach to treat multiple sclerosis
February 22, 2019 - $1.5 million grant to develop opioid treatment program for jail detainees
February 22, 2019 - FDA’s new proposed rule would update regulatory requirements for sunscreen products in the U.S
February 22, 2019 - Most Hip, Knee Replacements Last Decades, Study Finds
February 22, 2019 - Wellness problems prevalent among ob-gyn residents
February 22, 2019 - In the Spotlight: “The world is your oyster in geriatrics”
February 22, 2019 - Successful testing of multi-organ “human-on-a-chip” could replace animals as test subjects
February 22, 2019 - Analysis of cervical precancer shows decline in two strains of HPV
February 22, 2019 - Sugary stent eases suturing of blood vessels
February 22, 2019 - From surgery to psychiatry: A medical student reevaluates his motivations
February 22, 2019 - Is New App From Feds Your Answer To Navigating Medicare Coverage? Yes And No
February 22, 2019 - New pacemakers powered by heartbeats could reduce need for surgery
February 22, 2019 - The United States records highest drug overdose death rates
February 22, 2019 - Phase 1 data reinforce safety profile of new drug for treating Duchenne muscular dystrophy
February 22, 2019 - Vitamin D supplementation less effective in the presence of obesity, shows study
February 22, 2019 - Novostia raises CHF 6.5 million to advance its aortic, mitral heart valve to clinical trials
February 22, 2019 - CPRIT awards nearly $20 million to The University of Texas MD Anderson Cancer Center
February 22, 2019 - Sarepta Announces FDA Acceptance of Golodirsen (SRP-4053) New Drug Application for Patients with Duchenne Muscular Dystrophy Amenable to Skipping Exon 53
February 22, 2019 - An institutional effort to reduce the amount of opioids prescribed following lumbar surgery
February 22, 2019 - Family-history-based models perform better than non-family-history based models
February 22, 2019 - Failure to take statins leads to higher mortality rates | News Center
February 22, 2019 - New study explains why some patients report phantom sensations after limb amputation
February 22, 2019 - First motor-controlled heart valves implanted by Mainz University Medical Center
February 22, 2019 - Novel preclinical model mimics persistent interneuron loss seen in preterm infants
February 22, 2019 - Global health burden of glaucoma has increased, study reveals
February 22, 2019 - A holistic approach key to minimize treatment complexity in patients with interstitial lung disease
February 22, 2019 - 1 in 10 middle-aged Chinese adults are at high risk for heart disease, finds study
February 22, 2019 - More than half a million breast cancer patient’s lives saved by improvements in treatment
February 22, 2019 - Study finds no evidence that tougher policies prevent teenage cannabis use
February 22, 2019 - New blood test detects genetic disorders in fetuses
February 22, 2019 - Lower Self-Perception Observed in Children With Amblyopia
February 22, 2019 - Up to 15 percent of children have sleep apnea, yet 90 percent go undiagnosed
February 22, 2019 - Rare pulmonary defect prompts parents’ nationwide search for answers | News Center
February 22, 2019 - Lesbian and bisexual women at greater risk of being overweight, study finds
February 22, 2019 - UQ research may explain why vitamin D is essential for brain health
February 22, 2019 - Heart Attacks Rising Among Younger Women
February 22, 2019 - How your smartphone is affecting your relationship
February 22, 2019 - Orthopaedic surgeon receives prestigious award, $10 million grant | News Center
February 22, 2019 - New sepsis test could save thousands of lives
February 22, 2019 - Cervical cancer could be eradicated by 2100
February 21, 2019 - Sustained smoking cessation can lower risk of seropositive RA
February 21, 2019 - Thousands with chronic UTIs are not receiving the treatment they need
February 21, 2019 - Are teens getting high on social media? The surprising study seeking the pot-Instagram link
February 21, 2019 - Stanford expands biobank services | News Center
February 21, 2019 - Scientists identify link between drinking contexts and early onset intoxication among adolescents
February 21, 2019 - Strong social support may reduce cardiovascular disease risk in postmenopausal women
February 21, 2019 - Rapid expansion of interventions could prevent up to 13 million cases of cervical cancer within 50 years
February 21, 2019 - Motif Bio Receives Complete Response Letter From The FDA
February 21, 2019 - Researchers map previously unknown disease in children
February 21, 2019 - A skeptical look at popular diets: Going gluten-free
February 21, 2019 - Podcast: KHN’s ‘What The Health?’ How Safe Are Your Supplements?
February 21, 2019 - Factors associated with increased risk of developing surgical site infections
February 21, 2019 - Anticipatory signals in eye movements can help measure attentive capacity, learning with greater precision
February 21, 2019 - Study explores daily exposure to indoor air pollutants
February 21, 2019 - Evening exercise does not negatively affect sleep, may also reduce hunger
February 21, 2019 - Artificial intelligence technique can be used to identify alcohol misuse in trauma setting
Women with epilepsy have five times greater risk of dying during pregnancy

Women with epilepsy have five times greater risk of dying during pregnancy

image_pdfDownload PDFimage_print

The risk of dying during pregnancy is negligible for the average Danish woman, but if the woman in question has epilepsy, the probability must be multiplied by five. This is the central result presented in a comprehensive epidemiological study that researchers from Health, Aarhus University, are behind.

The study is recently published in the journal Neurology and shows that out of approximately two million pregnant women – including 12,000 women with epilepsy – a total of 176 women died during their pregnancy. Five of them had epilepsy, which means women with epilepsy are a risk group that we should consider following closer, says one of the researchers behind the study, Jakob Christensen. He is a clinical associate professor, DMSc at the Department of Clinical Medicine at Aarhus University and a consultant at the Department of Neurology at Aarhus University Hospital.

“Although the absolute risk is small, we have to consider how we can follow pregnant women with epilepsy better than today,” says Jakob Christensen.

According to the study, pregnant women with epilepsy die of virtually the same conditions and events that women without epilepsy also die of – ranging from e.g. accidents to blood clots, cancer and suicide – although with a greater frequency.

“We can’t produce statistics on causes of death on the basis of five deceased pregnant women with epilepsy, but we can conclude with great statistical certainty that pregnant women with epilepsy die five times more frequently than other pregnant women,” says Jakob Christensen.

The research results should be seen in light of the fact that in general, people with epilepsy have a higher mortality rate than the rest of the population. Overall, for women of childbearing age the mortality rate is fifteen times higher.

The relative risk of death is thus lower for women with epilepsy who are also pregnant when compared to all women with epilepsy, which as Jakob Christensen points out, may be due to the fact that it is always the most healthy woman who become pregnant.

“As a woman with epilepsy, you are on the one hand affiliated with highly-specialised neurological treatment at a hospital, while on the other hand, you need follow-ups from your general practitioner. Patients in this situation risk falling between two stools and ending up being sent back and forth, as one medical service believes the other is taking overall responsibility and vice versa. This could be a partial explanation for the increased mortality, which is particularly seen in people with epilepsy who at the same time suffer from mental illness – something that is unfortunately well documented, for example in Swedish patients with mental illness,” says Jakob Christensen.

“At the same time, we must take into account that the vast majority of pregnant women with epilepsy receive medication and are closely monitored during pregnancy, and that this probably helps to reduce the overall mortality, because close monitoring means that there is better management of their epileptic seizures,” he says.

The study was conducted in close collaboration between Jakob Christensen, who meets the patients in the clinical reality, statistician Claus Høstrup Vestergaard from the Research Unit for General Practice under the Department of Public Health, and Associate Professor Bodil Hammer Bech, who works with epidemiology at the Department of Public Health.

Methodically, the research group has examined a total of 2,110,084 pregnancies between 2000 and 2013. Among these pregnancies, 11,976 (0.6%) were pregnancies among women with epilepsy; in all cases, “pregnancy-related death” was defined as death during pregnancy and up to 42 days after the end of the pregnancy. Mortality among women with epilepsy was compared with the mortality rate for women of the same age and social background.

The Danish study is the result of a number of worrying studies from the US and UK which report a tenfold increase in the risk of dying for pregnant women with epilepsy. But things do not look quite as bad in Denmark.

“Even though it can be difficult to compare Denmark with the United States and the UK because the healthcare systems are constructed differently, the study indicates that in Denmark, we’re better at dealing with pregnant women with epilepsy than they are in the United States and the United Kingdom, which we should naturally be pleased about.

But this is of little consolation for the pregnant Danish women with epilepsy who still have a markedly increased risk of losing their lives during pregnancy. And I definitely think that we should take an interest in this as medical doctors,” says Jakob Christensen.

More information about epilepsy

Epilepsy is one of the most common neurological diseases. Epilepsy can have many different causes, manifestations and prognoses.

The common denominator is recurrent epileptic seizures as a result of the signal traffic in larger or smaller networks of nerve cells in the brain ‘getting out of control’.

Worldwide, approximately sixty million people have epilepsy.

Epilepsy affects twelve Danes every day. A total of 50,000 are diagnosed with in Denmark – of these, 65 per cent are free of seizures.

The majority of women with epilepsy can become pregnant and have healthy children, but pregnancy in women with epilepsy requires preparation and planning in consultation with a medical doctor, because both frequent epileptic seizures and epilepsy medicine can harm the child.

Tagged with:

About author

Related Articles